Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs

…, A Bedbrook, B Beghé, M Beji, EH Bel… - Journal of Allergy and …, 2012 - Elsevier
Allergic rhinitis (AR) and asthma represent global health problems for all age groups.
Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on …

Clinical phenotypes of asthma

EH Bel - Current opinion in pulmonary medicine, 2004 - journals.lww.com
The classic phenotype of IgE-mediated asthma starting in childhood is now clearly defined.
However, many other phenotypes of asthma in childhood as well in adulthood are being …

Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)

EH Bel, A Sousa, L Fleming, A Bush, KF Chung… - Thorax, 2011 - thorax.bmj.com
… Elisabeth H Bel1, … , Department of Respiratory Medicine, Academic Medical Centre, University
of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; ehbel{at}… Bel EH

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

…, IM Adcock, ED Bateman, EH Bel… - European respiratory …, 2014 - Eur Respiratory Soc
Severe or therapy-resistant asthma is increasingly recognised as a major unmet need. A
Task Force, supported by the European Respiratory Society and American Thoracic Society, …

[HTML][HTML] Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma

EH Bel, SE Wenzel, PJ Thompson… - New England journal …, 2014 - Mass Medical Soc
Background Many patients with severe asthma require regular treatment with oral glucocorticoids
despite the use of high-dose inhaled therapy. However, the regular use of systemic …

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment

JK Sont, LNA Willems, EH Bel… - American journal of …, 1999 - atsjournals.org
According to international guidelines, the level and adjustment of antiinflammatory treatment
for asthma are based solely on symptoms and lung function. We investigated whether a …

The prevalence of severe refractory asthma

…, M Amelink, AH Zwinderman, ML Bouvy, EH Bel - Journal of Allergy and …, 2015 - Elsevier
EH Bel has received compensation for board membership from Novartis, as well as
consultancy fees from GlaxoSmithKline, Regeneron, and CIPLA and has received or has grants …

Risk factors of frequent exacerbations in difficult-to-treat asthma

…, AH Zwinderman, KF Rabe, EH Bel - European …, 2005 - Eur Respiratory Soc
Recurrent exacerbations are a major cause of morbidity and medical expenditure in patients
with asthma. Various exogenous and endogenous factors are thought to influence the level …

Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

…, J Corfield, I Pandis, AT Bansal, EH Bel… - European …, 2015 - Eur Respiratory Soc
U-BIOPRED is a European Union consortium of 20 academic institutions, 11 pharmaceutical
companies and six patient organisations with the objective of improving the understanding …

An electronic nose in the discrimination of patients with asthma and controls

…, O Resta, NP Willard, TJ Vink, KF Rabe, EH Bel… - Journal of allergy and …, 2007 - Elsevier
BACKGROUND: Exhaled breath contains thousands of volatile organic compounds (VOCs)
that could serve as biomarkers of lung disease. Electronic noses can distinguish VOC …